Suppression of cellular transformation by glucocorticoid receptor mutants

Cancer Research

Volumn 58, Issue 5, 1998, Pages 867-870

  Kameda, Takashi ^a   Iba, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ONCOPROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CHICK EMBRYO; CONTROLLED STUDY; FIBROBLAST; HORMONE RESPONSIVE ELEMENT; NONHUMAN; ONCOGENE; ONCOGENE C FOS; ONCOGENE C H RAS; ONCOGENE C JUN; PRIORITY JOURNAL; TRANSACTIVATION;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GENES, SRC; GENETIC VECTORS; MUTATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, GLUCOCORTICOID; RETROVIRIDAE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 0032031061     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Scribner, J. D., and Slaga, T. J. Multiple effects of dexamethasone on protein synthesis and hyperplasia caused by a tumor promoter. Cancer Res., 33: 542-546, 1973.
2. Strawhecker, J. M., and Pelling, J. C. Inhibition of mouse skin tumorigenesis by dexamethasone occurs through a Ha-ras-independent mechanism. Carcinogenesis (Lond.), 13: 2075-2080, 1992.
3. Cato, A. C. B., and Wade, E. Molecular mechanisms of antiinflammatory action of glucocorticoids. BioEssays, 18: 371-378, 1996.
4. Jonat, C., Rahmsdorf, H. J., Park, K. K., Cato, A. C. B., Gebel, S., Ponta, H., and Herrlich, P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell, 62: 1189-1204, 1990.
5. Beato, M., Herrlich, P., and Schütz, G. Steroid hormone receptors: many actors in search of a plot. Cell, 83: 851-857, 1995.
6. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocr. Rev., 14: 651-658, 1993.
7. Cohen, D. R., Ferreira, P. C., Gentz, R., Franza, B., Jr., and Curran, T. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev., 3: 173-184, 1989.
8. Rauscher, F. J., Cohen, D. R., Curran, T., Bos, T. J., Vogt, P. K., Bohmann, D., Tjian, R., and Franza, B. R. Fos-associated protein p39 is the product of the jun protooncogene. Science (Washington DC), 240: 1010-1016, 1988.
9. Suzuki, T., Okuno, H., Yoshida, T., Endo, T., Nishina, H., and Iba, H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucl. Acids Res., 19: 5537-5542, 1991.
10. Zerial, M., Toschi, L., Ryseck, R. P., Schuermann, M., Müller, R., and Bravo, R. The product of a novel growth factor activated gene, fosB, interacts with JUN proteins enhancing their DNA binding activity. EMBO J., 8: 805-813, 1989.
11. Suzuki, T., Murakami, M., Onai, N., Fukuda, E., Hashimoto, Y., Sonobe, M. H., Kameda, T., Ichinose, M., Miki, K., and Iba, H. Analysis of AP-1 function in cellular transformation pathways. J. Virol., 68: 3527-3535, 1994.
12. Kameda, T., Watanabe, H., and Iba, H. c-Jun and JunD suppress maturation of chondrocytes. Cell Growth Differ., 8: 495-503, 1997.
13. Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature (Lond.), 330: 624-629, 1987.
14. Iba, H., Nishina, H., Shindo, Y., and Yoshida, T. Transforming potential and growth stimulating activity of the v-fos and c-fos genes carried by avian retrovirus vectors. Oncogene Res., 2: 121-133, 1988.
15. Hollenberg, S. M., Giguere, V., Segui, P., and Evans, R. M. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell, 49: 39-46, 1987.
16. Parthasarathy, S., Morales, A. J., and Murphy, A. A. Antioxidant: a new role for RU-486 and related compounds. J. Clin. Invest., 94: 1990-1995, 1994.
17. Mooradian, A. D. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol., 45: 509-511.
18. Schule, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., and Evans, R. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell, 62: 1217-1226, 1990.
19. Danielian, P. S., White, R., Lees, J. A., and Parker, M. G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J., 11: 1025-1033, 1992.
20. Hollenberg, S. M., and Evans, R. M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell, 55: 899-906, 1988.
21. Howard, K. J., Holley, S. J., Yamamoto, K. R., and Distelhorst, C. W. Mapping the HSP90 binding region of the glucocorticoid receptor. J. Biol. Chem., 265: 11928-11935, 1990.
22. Webster, N. J. G., Green, S., Jin, J. R., and Chambon, P. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell, 54: 199-207, 1988.
23. Kameda, T., Akahori, A., Sonobe, M. H., Suzuki, T., Endo, T., and Iba, H. JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2. Proc. Natl. Acad. Sci. USA, 90: 9369-9373, 1993.
24. Bannister, A. J., and Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature (Lond.), 384: 641-643, 1996.
25. Ogryzko, V. V., Scjlitz, R. L., Russanova, V., Howard, B., and Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87: 953-959, 1996.
26. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurosawa, R., Gloss, B., Lin, S-C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85: 403-414, 1996.